NPY receptors as potential targets for anti‐obesity drug development
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
The neuropeptide Y system has proven to be one of the most important regulators of feeding behaviour and energy homeostasis, thus presenting great potential as a therapeutic target for the treatment of disorders such as obesity and at the other extreme, anorexia. Due to the initial lack of pharmacological tools that are active in vivo, functions of the different Y receptors have been mainly studied in knockout and transgenic mouse models. However, over recent years various Y receptor selective peptidic and non‐peptidic agonists and antagonists have been developed and tested. Their therapeutic potential in relation to treating obesity and other disorders of energy homeostasis is discussed in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut hormone PYY3-36 physiologically inhibits food intake
Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., et al. (2002) · Nature · doi:10.1038/nature00887 · Cited by 2,351 · cited 12×
“Moreover, the anorectic effect of intraperitonally administered PYY3-36 was abolished in mice deficient of Y2 receptors (Batterham et al., 2002), or in wildtype rodents in which PYY3-36 was co-administered with the Y2 receptor antagonist BIIE0246 (Abbott et al., 2005; Scott et al., 2005; Talsania…”
BackgroundResultInfluentialSelf-citationInhibition of Food Intake in Obese Subjects by Peptide YY 3–36
Batterham, R. L., Cohen, M. A., Ellis, S. M., Le Roux, C. W., Withers, D. J., Frost, G. S., Ghatei, M. A., & Bloom, S. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030204 · Cited by 1,604 · cited 5×
“Indeed, short-term i.v. administration of PP to lean human subjects led to sustained suppression of appetite and food intake up to 24 h post-infusion (Batterham et al., 2003b; Jesudason et al., 2007.”
BackgroundResultInfluentialSchwartz, M. W., Baskin, D. G., Bukowski, T. R., Kuijper, J. L., Foster, D., Lasser, G., Prunkard, D. E., Porte, D., Woods, S. C., Seeley, R. J., et al. (1996) · Diabetes · doi:10.2337/diab.45.4.531 · Cited by 904 · cited 2×
“…difference could be due to a greater predisposition to body weight gain in the genetically obese mice relative to wild-type animals, it is also likely that the efficacy of S-2367 may be enhanced in conditions of elevated hypothalamic NPY expression levels, as in ob/ob mice (Schwartz et al., 1996).”
BackgroundGlenn Stanley, B., Kyrkouli, S. E., Lampert, S., & Leibowitz, S. F. (1986) · Peptides · doi:10.1016/0196-9781(86)90149-x · Cited by 849 · cited 1×
“Central administration of NPY to rats and mice induces hyperphagia, decreases energy expenditure, activates lipogenic enzymes in the liver and adipose tissues, collectively contributing to the development of obesity (Stanley et al., 1986; Zarjevski et al., 1993; Lin et al., 2006).”
BackgroundKuo, L. E., Kitlinska, J. B., Tilan, J. U., Li, L., Baker, S. B., Johnson, M. D., Lee, E. W., Burnett, M. S., Fricke, S. T., Kvetnansky, R., et al. (2007) · Nature Medicine · doi:10.1038/nm1611 · Cited by 656 · cited 2×
“Y2 receptors are involved in promoting the proliferation and differentiations of adipocytes as well as stimulating angiogenesis of capillaries in adipose tissue (Kuo et al., 2007).”
BackgroundSelf-citationPancreatic Polypeptide Reduces Appetite and Food Intake in Humans
Batterham, R. L., Le Roux, C. W., Cohen, M. A., Park, A. J., Ellis, S. M., Patterson, M., Frost, G. S., Ghatei, M. A., & Bloom, S. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030630 · Cited by 496
Mechanical signals as anabolic agents in bone
Ozcivici, E., Luu, Y. K., Adler, B., Qin, Y.-X., Rubin, J., Judex, S., & Rubin, C. T. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.239 · Cited by 441
Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity
Boey, D., Lin, S., Karl, T., Baldock, P., Lee, N., Enriquez, R., Couzens, M., Slack, K., Dallmann, R., Sainsbury, A., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0237-0 · Cited by 186
Self-citationEfficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults
Gantz, I., Erondu, N., Mallick, M., Musser, B., Krishna, R., Tanaka, W. K., Snyder, K., Stevens, C., Stroh, M. A., Zhu, H., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1806 · Cited by 163 · cited 2×
“PYY3-36 infusion, particularly at higher doses (Degen et al., 2005; Gantz et al., 2007; Sloth et al., 2007a; le Roux et al., 2008).”
BackgroundRoles of pancreatic polypeptide in regulation of food intake
Katsuura, G., Asakawa, A., & Inui, A. (2002) · Peptides · doi:10.1016/s0196-9781(01)00604-0 · Cited by 155 · cited 4×
“…the vago-vagal reflex arc in the area postrema, and relays anorexigenic signalling from PP in the peripheral circulation to the hypothalamus (Katsuura et al., 2002; Lin et al., 2009), as well as being critically important in the regulation of reproductive functions (Sainsbury et al., 2010).”
BackgroundInfluentialKishi, T., Aschkenasi, C. J., Choi, B. J., Lopez, M. E., Lee, C. E., Liu, H., Hollenberg, A. N., Friedman, J. M., & Elmquist, J. K. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20432 · Cited by 119 · cited 2×
“In line with the previously reported distribution of NPY and predicted NPY binding sites (Adrian, 1978), Y1 receptor expression, detected using in situ hybridization and immunohistochemistry, was found in several thalamic nuclei, in the hippocampus, various amygdaloid nuclei and in the hypothalamus of the rat and mous…”
BackgroundResultEvidence that neuropeptide Y is a physiological signal for normal food intake
Dube, M. G., Xu, B., Crowley, W. R., Kalra, P. S., & Kalra, S. P. (1994) · Brain Research · doi:10.1016/0006-8993(94)90103-1 · Cited by 119
Sloth, B., Davidsen, L., Holst, J. J., Flint, A., & Astrup, A. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00153.2007 · Cited by 104 · cited 13×
“…obese people remain responsive to the anorectic effect of exogenous PYY3-36, at least to an acute i.v. infusion (Batterham et al., 2003b; Sloth et al., 2007a; 2007b; Field et al., 2010), and this effect can be additive with other anorexic agents such as the glucagon-like peptide (GLP-1)…”
BackgroundResultInfluentialMorgan, D. G., Kulkarni, R. N., Hurley, J. D., Wang, Z. L., Wang, R. M., Ghatei, M. A., Karlsen, A. E., Bloom, S. R., & Smith, D. M. (1998) · Diabetologia · doi:10.1007/s001250051095 · Cited by 79 · cited 2×
“Evaluation of peripheral tissues revealed Y1 receptor mRNA in the colon (Goumain et al., 1998), pancreatic b cells (Morgan et al., 1998) and in the visceral adipose tissues of rats (Yang et al., 2008).”
BackgroundSchonhoff, S., Baggio, L., Ratineau, C., Ray, S. K., Lindner, J., Magnuson, M. A., Drucker, D. J., & Leiter, A. B. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.10.4189-4199.2005 · Cited by 53 · cited 3×
“Moreover, the founder colony used in this study was on an FVB background, a mouse strain that has been shown to be resistant to obesity induced by feeding a high-fat diet or by carrying a transgene that normally leads to obesity on a C57Bl/6 background (Ludwig et al., 2001; Chen et al., 2005; Schonhoff et al., 2005).”
BackgroundMethod
Cited by
Broza, Y. Y., Zhou, X., Yuan, M., Qu, D., Zheng, Y., Vishinkin, R., Khatib, M., Wu, W., & Haick, H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00437 · Cited by 461
Neuropeptides and the Microbiota-Gut-Brain Axis
Holzer, P., & Farzi, A. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-0897-4_9 · Cited by 451
Emerging role of the brain in the homeostatic regulation of energy and glucose metabolism
Roh, E., Song, D. K., & Kim, M.-S. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.4 · Cited by 396
Peptides Containing β-Amino Acid Patterns: Challenges and Successes in Medicinal Chemistry
Cabrele, C., Martinek, T. A., Reiser, O., & Berlicki, Ł. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5010896 · Cited by 368
Regulation of energy homeostasis by the NPY system
Loh, K., Herzog, H., & Shi, Y.-C. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.01.003 · Cited by 293
Self-citation
Metadata
- Authors
- Yulyaningsih, E., Zhang, L., Herzog, H., & Sainsbury, A.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2011-06-27
- Volume
- 163
- Issue
- 6
- Pages
- 1170-1202
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2139273810
- Cited by
- 138
- References
- 15
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.